Matthew Earl

The Trump II Administration is active in terms of regulating…and placing restrictions on…DME suppliers. Prime examples of these are OIG advisory opinions, fraud alerts, advisory bulletins and other written guidance. This program will discuss the most recent OIG guidance on issues vitally important to DME suppliers, including (i) subscribing to online referral programs, (ii) working with telehealth companies, (iii) joint ventures and other contracts with hospitals, long-term care facilities, and other referral sources, (iv) implementation of marketing programs, and (v) strategic relationships with physicians. Importantly, in light of OIG guidance, this program will discuss how arrangements and programs can be properly structured…and those that lead to a risk of an OIG enforcement action.

DMEPOS suppliers face increasing scrutiny from CMS and other regulators making enrollment compliance more important than ever. A revocation of a supplier’s Medicare PTAN can have significant operational and financial consequences, ranging from payment disruptions to lengthy reenrollment bars. Understanding the enrollment process, maintaining compliance with the Medicare Supplier Standards, and effectively responding to adverse enrollment actions are critical to protecting a supplier's business.

This webinar will provide a practical overview of Medicare DMEPOS enrollment requirements, common enrollment pitfalls that lead to revocations, and the appeals process available to suppliers. Attendees will gain insight into revocation authorities, reenrollment bars, corrective action plans, reconsideration requests, and strategies for building a successful defense when CMS or its contractors come knocking.